Clinical Trial Update: A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) [Phase 2]

View source ↗

Summary

Phase 2 trial of multiple oral doses of linaclotide in children 6-17 with functional constipation completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation in Children Ages 6-17 Years

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Forest Laboratories | Conditions: Functional Constipation in Children Ages 6-17 Years | Phase 2 | Status: COMPLETED | Results posted: 2019-05-14